Australia, Aug. 6 -- Prenostics Ltd., owns the trademark (2549890) for 'PRENOSTICS' and 'DOT IN CIRCLE,BROKEN IS LTR O' till March 31, 2035.
Status: protected:
Registered/protected
Classes: 1 [In-vivo diagnostic reagents for scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific or research use.], 5 [Medical diagnostic reagents; clinical diagnostic reagents; reagents for use in diagnostic tests [for medical purposes]; medical diagnostic reagents and assays for testing of body fluids; diagnostic biomarker reagents for medical purposes; diagnostic reagents for medical use; reagents and media for medical and veterinary diagnostic purposes; diagnostic testing materials for medical use; chemical diagnostic reagents for medical use; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; indicators for medical diagnosis; reagents for use in medical genetic testing; diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; reagents for use with analyzers [for medical purposes]; diagnostic agents for medical use; radio-isotope markers for therapeutic or diagnostic use; biopharmaceuticals for the treatment of cancer; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the prevention of tumours; anti-cancer drugs; chemotherapeutics; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for suppressing tumors; tumor suppressing agents; protein synthesis inhibitors; neoantigens; diagnostic radiopharmaceutical preparations; clinical medical reagents.], 10 [Tools for medical diagnostics; diagnostic testing instruments for use in immunoassay procedure [medical]; testing probes for medical diagnostic purposes; diagnostic, examination, and monitoring equipment; diagnostic testing apparatus for use in immunoassay procedures [medical]; medical diagnostic instruments; testing instruments for medical diagnostic purposes; nuclear medicine diagnostic imaging apparatus; spectrum analyzers for use in medical diagnosis; diagnostic imaging apparatus for medical use; diagnostic instruments for medical use; diagnostic apparatus for medical purposes; medical diagnostic apparatus for medical purposes; apparatus for the treatment of cancer; apparatus for tumour diagnosis.], 42 [Design and development of medical technology; computer diagnostic services; development of diagnostic apparatus; research and development in the field of diagnostic preparations; scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; medical research; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; advice on scientific information relating to alleviation, diagnosis, prevention and treatment of cancer; administration of research in the fields of health, diet, nutrition, cancer and cancer prevention; research laboratories; preparation of biological samples for testing and analysis in research laboratories; provision of information and data relating to medical and veterinary research and development; laboratories; all of the aforesaid services provided in relation to cancer diagnosis, treatment and therapy.] and 44 [Medical diagnostic services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis of cancer; remote monitoring of medical data for medical diagnosis and treatment; medical analysis services for cancer diagnosis and prognosis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases; prostate cancer screening services; breast cancer screening services; lung cancer screening services; testicular cancer screening services; cervical cancer screening services; bowel cancer screening services; medical services for the treatment of skin cancer; RNA or DNA analysis for cancer diagnosis and prognosis; providing cancer screening services; analysis of human tissues for medical treatment; advisory services relating to the treatment of degenerative diseases; analysis of human serum for medical treatment; health care; health risk assessment; advice relating to the personal welfare of elderly people [health]; all of the aforesaid services provided in relation to cancer diagnosis, treatment and therapy.]
Type of Mark: Figurative
Date of Acceptance: May 29
Registration Advertised: Aug. 5
For further details contact Banki Haddock Fiora and CMS Cameron McKenna Nabarro Olswang LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2549890.
Disclaimer: Curated by HT Syndication.
